Telemetry Investments, L.L.C. Amarin Corp Plcuk Call Options Transaction History

Telemetry Investments, L.L.C.

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2019 Aug 14, 2019	SELL	$16.27 - $20.51 $325,400 - $410,200	-20,000 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$12.61 - $22.33 $75,660 - $133,980	-6,000 Reduced 23.08%	20,000 $415,000
Q4 2018 Feb 14, 2019	BUY	$12.41 - $22.98 $322,660 - $597,480	26,000 New	26,000 $354,000
Q3 2018 Nov 14, 2018	SELL	$2.45 - $16.27 $158,760 - $1.05 Million	-64,800 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$2.99 - $4.44 $163,852 - $243,312	54,800 Added 548.0%	64,800 $195,000
Q4 2017 Feb 14, 2018	BUY	$3.06 - $4.09 $30,600 - $40,900	10,000	10,000 $40,000

178

65.3M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $210M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Telemetry Investments, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Telemetry Investments, L.L.C. with notifications on news.